African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development
Genetic diversity is greater in Africa than in other continental populations. Genetic variability in genes encoding drug metabolizing enzymes may contribute to the high numbers of adverse drug reactions reported in Africa. We reviewed publications (1995–April 2016) reporting frequencies of known cyt...
Main Authors: | Iris Rajman, Laura Knapp, Thomas Morgan, Collen Masimirembwa |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396417300762 |
Similar Items
-
Inhibitory effects of herbal medicines with claimed anticancer indications on cytochrome P450—An evaluation of drug-herb interactions risk
by: Misheck Mudyiwa, et al.
Published: (2023-09-01) -
Assessment of Substrate Status of Drugs Metabolized by Polymorphic Cytochrome P450 (CYP) 2 Enzymes: An Analysis of a Large-Scale Dataset
by: Jakob Sommer, et al.
Published: (2024-01-01) -
The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo
by: Sychev DA, et al.
Published: (2018-05-01) -
Machine learning to predict metabolic drug interactions related to cytochrome P450 isozymes
by: Ning-Ning Wang, et al.
Published: (2022-04-01) -
Exploring the Kinh Vietnamese genomic database for the polymorphisms of the P450 genes towards precision public health
by: Diep Thi Hoang, et al.
Published: (2022-02-01)